Loading company…
Serenex discovers and develops small-molecule Hsp90 inhibitors.
Based in Durham, US, Serenex is an integrated drug discovery and development company focused on small-molecule Hsp90 inhibitors.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in